Cerus
CERS
$1.71
Share price
0.59%
Change (1 day)
-25.97%
Change (1 year)
Categories
Cerus (CERS) - P/B ratio
P/B ratio as of April 2024 : 5.80
According to Cerus's latest financial reports the company has a price-to-book ratio of 5.80.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Cerus - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 7.32 | -22.47% |
| 2022-12-31 | 9.45 | -31.62% |
| 2021-12-31 | 13.8 | 23.22% |
| 2020-12-31 | 11.2 | 5.04% |
| 2019-12-31 | 10.7 | 30.01% |
| 2018-12-31 | 8.21 | -18.15% |
| 2017-12-31 | 10.0 | 28.78% |
| 2016-12-31 | 7.79 | 17.85% |
| 2015-12-31 | 6.61 | -45.31% |
| 2014-12-31 | 12.1 | 11.57% |
| 2013-12-31 | 10.8 | 16.42% |
| 2012-12-31 | 9.30 | 26.5% |
| 2011-12-31 | 7.35 | 49.9% |
| 2010-12-31 | 4.91 | 36.71% |
| 2009-12-31 | 3.59 | 440.71% |
| 2008-12-31 | 0.6637 | -81.04% |
| 2007-12-31 | 3.50 | 90.05% |
| 2006-12-31 | 1.84 | -71.5% |
| 2005-12-31 | 6.46 | 111.93% |
| 2004-12-31 | 3.05 | 59.92% |
| 2003-12-31 | 1.91 | -68.77% |
| 2002-12-31 | 6.11 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | 5.51 | -5.06% | 🇺🇸 USA |
 Utah Medical Products UTMD | 1.91 | -67.03% | 🇺🇸 USA |
 Haemonetics HAE | 4.90 | -15.54% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 4.34 | -25.23% | 🇺🇸 USA |